A Quantitative Systems Pharmacology Model of Gaucher Disease Type 1 Provides Mechanistic Insight Into the Response to Substrate Reduction Therapy With Eliglustat
Abrams, Ruth, Kaddi, Chanchala D., Tao, Mengdi, Leiser, Randolph J., Simoni, Giulia, Reali, Federico, Tolsma, John, Jasper, Paul, Rijn, Zachary, Li, Jing, Niesner, Bradley, Barrett, Jeffrey S., MarcheVolume:
9
Journal:
CPT: Pharmacometrics & Systems Pharmacology
DOI:
10.1002/psp4.12506
Date:
July, 2020
File:
PDF, 1.28 MB
2020